A. Yassouridis

F. Holsboer, A. Yassouridis, H. Backmund, 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Oxytocin-stimulated release of adrenocorticotropin from the rat pituitary is mediated by arginine vasopressin receptors of the V1b type.

J. Elands, O. Almeida, A. Yassouridis, 1994, Endocrinology.

Reduced availability of milk after central injections of corticotropin-releasing hormone in lactating rats.

O. Almeida, A. Yassouridis, I. Forgas-Moya, 1994, Neuroendocrinology.

Ghrelin suppresses secretion of luteinizing hormone in humans.

A. Steiger, M. Uhr, M. Kluge, 2007, The Journal of clinical endocrinology and metabolism.

Antidepressants Differentially Influence the Transcriptional Activity of the Glucocorticoid Receptor in vitro

F. Holsboer, T. Rein, A. Yassouridis, 2003, Neuroendocrinology.

The mineralocorticoid receptor agonist, fludrocortisone, inhibits pituitary-adrenal activity in humans after pre-treatment with metyrapone.

C. Otte, K. Wiedemann, M. Kellner, 2003, Life sciences.

GABA(A) receptor-modulating neuroactive steroid composition in patients with panic disorder before and during paroxetine treatment.

F. Holsboer, A. Ströhle, R. Rupprecht, 2002, The American journal of psychiatry.

Mineralocorticoid receptor function in patients with posttraumatic stress disorder.

C. Otte, D. Naber, D. Baker, 2002, The American journal of psychiatry.

The influence of two behavioral regimens on the distribution of sleep and wakefulness in narcoleptic patients.

H. Schulz, J. Wilde-Frenz, A. Yassouridis, 1990, Sleep.

Endocrine and Cardiovascular Responses to Corticotropin-Releasing Hormone in Patients with Posttraumatic Stress Disorder: A Role for Atrial Natriuretic Peptide?

D. Baker, K. Wiedemann, M. Kellner, 2003, Neuropsychobiology.

Distinct panicogenic activity of sodium lactate and cholecystokinin tetrapeptide in patients with panic disorder.

F. Holsboer, A. Ströhle, J. Plag, 2012, Current pharmaceutical design.

Ghrelin suppresses secretion of FSH in males

A. Steiger, M. Uhr, M. Kluge, 2009, Clinical endocrinology.

Modulation of sympathetic activity by corticotropin-releasing hormone and atrial natriuretic peptide

A. Ströhle, K. Wiedemann, M. Kellner, 2003, Neuropeptides.

Ghrelin alone or co-administered with GHRH or CRH increases non-REM sleep and decreases REM sleep in young males

A. Steiger, M. Uhr, M. Kluge, 2008, Psychoneuroendocrinology.

Intravenous C-type natriuretic peptide augments behavioral and endocrine effects of cholecystokinin tetrapeptide in healthy men.

K. Wiedemann, M. Kellner, H. Jahn, 2002, Journal of psychiatric research.

Clinical outcome after trimipramine in patients with delusional depression - a pilot study.

P. Baumann, R. Frieboes, A. Yassouridis, 2003, Pharmacopsychiatry.

No tolerance to peripheral morphine analgesia in presence of opioid expression in inflamed synovia.

A. Hassan, C. Stein, A. Yassouridis, 1996, The Journal of clinical investigation.

Treatment of benzodiazepine withdrawal symptoms with carbamazepine

H. Emrich, D. Garcia-Borreguero, A. Yassouridis, 2005, European Archives of Psychiatry and Clinical Neuroscience.

Modelling and exploring human sleep with event history analysis

L Fahrmeir, A Klinger, L. Fahrmeir, 1999, Journal of sleep research.

Neither major depression nor glucocorticoid treatment affects the cellular integrity of the human hippocampus

F. Holsboer, D. Swaab, M. Müller, 2001, The European journal of neuroscience.

Modulation of the mineralocorticoid receptor as add-on treatment in depression: a randomized, double-blind, placebo-controlled proof-of-concept study.

C. Otte, S. Moritz, K. Hinkelmann, 2010, Journal of psychiatric research.

No Effects of Antidepressants on Negative Symptoms in Schizophrenia

T. Raedler, K. Hinkelmann, K. Wiedemann, 2013, Journal of clinical psychopharmacology.

Presynaptic auto- and allelo-receptor regulation of hypothalamic opioid peptide release

A. Herz, O. Almeida, A. Yassouridis, 1989, Neuroscience.

Sleep disturbances in highly stress reactive mice: Modeling endophenotypes of major depression

F. Holsboer, T. Fenzl, M. Kimura, 2011, BMC Neuroscience.

Corticotropin-releasing hormone inhibits melatonin secretion in healthy volunteers--a potential link to low-melatonin syndrome in depression?

A. Steiger, F. Holsboer, K. Wiedemann, 1997, Neuroendocrinology.

Pituitary-adrenal-system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and normal comparison subjects.

I. Heuser, F. Holsboer, U. Schweiger, 1996, The American journal of psychiatry.

Penetration of Amitriptyline, but Not of Fluoxetine, into Brain is Enhanced in Mice with Blood-Brain Barrier Deficiency Due to Mdr1a P-Glycoprotein Gene Disruption

F. Holsboer, T. Steckler, M. Uhr, 2000, Neuropsychopharmacology.

Predictors of neuropsychiatric side effects of dopamine-agonist therapy in patients with prolactinomas

G. Stalla, M. Ising, M. Uhr, 2012 .

Antinociceptive effects of μ- and κ-agonists in inflammation are enhanced by a peripheral opioid receptor-specific mechanism

A. Herz, M. Millan, C. Stein, 1988 .

Opioids as novel intra-articular agents in arthritis

C. Stein, A. Yassouridis, K. Lehrberger, 1993 .

Antinociceptive effects of mu- and kappa-agonists in inflammation are enhanced by a peripheral opioid receptor-specific mechanism.

A. Herz, M. Millan, C. Stein, 1988, European journal of pharmacology.

Effects of a metabotropic glutamate2/3 receptor agonist (LY544344/LY354740) on panic anxiety induced by cholecystokinin tetrapeptide in healthy humans: preliminary results

C. Muhtz, K. Wiedemann, M. Kellner, 2005, Psychopharmacology.

Multiple sclerosis: comparison of copolymer-1- reactive T cell lines from treated and untreated subjects reveals cytokine shift from T helper 1 to T helper 2 cells.

C. Farina, R. Hohlfeld, H. Wiendl, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Interferon β‐1a reduces increased interleukin‐16 levels in multiple sclerosis patients

G. Krishnamoorthy, F. Weber, A. Yassouridis, 2014, Acta neurologica Scandinavica.

Can surgical reconstruction of vaginal and ligamentous laxity cure overactive bladder symptoms in women with pelvic organ prolapse?

J. Roovers, S. Sutherland, A. Yassouridis, 2018, BJU international.

The impact of sacrospinous ligament fixation on pre-existing nocturia and co-existing pelvic floor dysfunction symptoms

J. Roovers, S. Sutherland, A. Yassouridis, 2020, International Urogynecology Journal.

Cure of Underactive and Overactive Bladder Symptoms in Women by 1,671 Apical Sling Operations Gives Fresh Insights into Pathogenesis and Need for Definition Change

A. Yassouridis, B. Liedl, H. Inoue, 2019, Urologia Internationalis.

Is Chronic Pelvic Pain in the female surgically curable by uterosacral / cardinal ligament repair ?

A. Yassouridis, F. Wagenlehner, Peter, 2016 .

Valproate monotherapy in the treatment of civilian patients with non-combat-related posttraumatic stress disorder: an open-label study.

C. Otte, K. Wiedemann, M. Kellner, 2004, Journal of clinical psychopharmacology.

Heritability of Sleep Electroencephalogram

Florian Holsboer, Alexander Yassouridis, Stefanie Kalus, 2008, Biological Psychiatry.

On paternity determination from multilocus DNA profiles

J. Epplen, A. Yassouridis, J. Epplen, 1991, Electrophoresis.

Influence of exogenous atrial natriuretic peptide on the nocturnal hypothalamic-pituitary-adrenal axis and sleep in healthy men

K. Wiedemann, M. Kellner, H. Jahn, 2010, Psychoneuroendocrinology.

The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis.

C. Flachskamm, D. Cota, M. Tschöp, 2003, The Journal of clinical investigation.

Neurobehavioural disturbances, rehabilitation outcome, and lesion site in patients after rupture and repair of anterior communicating artery aneurysm

H. Steiger, M. Prosiegel, A. Yassouridis, 1998, Journal of neurology, neurosurgery, and psychiatry.

Combined Treatment of Schizophrenic Psychoses with Haloperidol and Valproate

H. Emrich, R. Hellweg, M. Dose, 1998, Pharmacopsychiatry.

Effects of ghrelin on psychopathology, sleep and secretion of cortisol and growth hormone in patients with major depression.

M. Dresler, A. Steiger, M. Uhr, 2011, Journal of psychiatric research.

Ghrelin Plasma Levels Are Not Altered in Major Depression

A. Steiger, M. Uhr, M. Kluge, 2009, Neuropsychobiology.

Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol--a double-blind multicenter trial.

A. Steiger, F. Holsboer, S. Kasper, 2009, Journal of psychiatric research.

Polymorphisms of the drug transporter gene ABCB1 predict side effects of treatment with cabergoline in patients with PRL adenomas.

G. Stalla, M. Ising, M. Uhr, 2012, European journal of endocrinology.

Mineralocorticoid Receptor Function in Posttraumatic Stress Disorder After Pretreatment with Metyrapone

C. Otte, C. Muhtz, F. Kiefer, 2006, Biological Psychiatry.

Dehydroepiandrosterone Response to the Adrenocorticotropin Test and the Combined Dexamethasone and Corticotropin-Releasing Hormone Test in Patients with Multiple Sclerosis

F. Holsboer, F. Then Bergh, C. Trenkwalder, 1999, Neuroendocrinology.

Copeptin – A potential endocrine surrogate marker of CCK-4-induced panic symptoms?

A. Agorastos, K. Wiedemann, M. Kellner, 2017, Psychoneuroendocrinology.

Copeptin in CCK-4-induced panic in healthy man: Sexual dimorphisms in secretion pattern and panic response, but no correlation of copeptin with panic symptoms

P. Zwanzger, R. Rupprecht, K. Wiedemann, 2019, Psychoneuroendocrinology.

Altered nocturnal growth hormone (GH) secretion in obsessive compulsive disorder

M. Dresler, A. Steiger, M. Kluge, 2006, Psychoneuroendocrinology.

Clinical score system in the treatment of Cushing’s disease: failure to identify discriminative variables from the German Cushing’s Registry

G. Stalla, M. Auer, M. Reincke, 2019, Pituitary.

cabergoline in patients with PRL adenomas

G. Stalla, M. Ising, M. Uhr, 2012 .

Trimipramine and imipramine exert different effects on the sleep EEG and on nocturnal hormone secretion during treatment of major depression.

A. Steiger, F. Holsboer, J. Guldner, 1996, Depression.

Decreased recognition of negative affect after selective serotonin reuptake inhibition is dependent on genotype

C. Muhtz, K. Hinkelmann, K. Wiedemann, 2010, Psychiatry Research.

Endocannabinoids render exploratory behaviour largely independent of the test aversiveness: role of glutamatergic transmission

W. Jacob, G. Marsicano, C. Wotjak, 2009, Genes, brain, and behavior.

Dose-dependence of bacterial lipopolysaccharide (LPS) effects on peak response and time course of the immune-endocrine host response in humans

T. Pollmächer, C. Galanos, H. Vedder, 1999, Inflammation Research.

Differential Impact of Tetratricopeptide Repeat Proteins on the Steroid Hormone Receptors

G. Wochnik, T. Rein, N. Gassen, 2010, PloS one.

Are obese adolescents and young adults at higher risk for mental disorders? A community survey.

A. Henkel, C. Jacobi, A. Yassouridis, 2002, Obesity research.

Behavioral and endocrine response to cholecystokinin tetrapeptide in patients with posttraumatic stress disorder

F. Holsboer, R. Yehuda, K. Wiedemann, 2000, Biological Psychiatry.

Mental Health in Offspring of Traumatized Refugees with and without Post-traumatic Stress Disorder.

L. Jelinek, C. Wittekind, C. Muhtz, 2016, Stress and health : journal of the International Society for the Investigation of Stress.

Blockade of the Mineralocorticoid Receptor in Healthy Men: Effects on Experimentally Induced Panic Symptoms, Stress Hormones, and Cognition

C. Otte, S. Moritz, K. Wiedemann, 2007, Neuropsychopharmacology.

Systemic growth hormone-releasing hormone (GHRH) impairs sleep in healthy young women

A. Steiger, M. Ising, K. Held, 2007, Psychoneuroendocrinology.

Optimization of 3-Dimensional Imaging of the Breast Region With 3-Dimensional Laser Scanners

Gernot Brockmann, Katja Schwenzer-Zimmerer, Maximilian Eder, 2006, Annals of plastic surgery.

Sleep after intranasal progesterone vs. zolpidem and placebo in postmenopausal women – A randomized, double-blind cross over study

A. Steiger, C. Mattern, R. Rupprecht, 2018, Psychoneuroendocrinology.

Clinical and Neurobiological Effects of Tianeptine and Paroxetine in Major Depression

A. Steiger, F. Holsboer, J. Zihl, 2003, Journal of clinical psychopharmacology.

Psychiatric patient stratification using biosignatures based on cerebrospinal fluid protein expression clusters.

Mathias Uhlen, Florian Holsboer, Alexander Yassouridis, 2013, Journal of psychiatric research.

Antipsychotic effect of buprenorphine in schizophrenia.

H. Emrich, A. Yassouridis, C. Schmauss, 1987, The American journal of psychiatry.

Prediction of medium-term outcome by cortisol response to the combined dexamethasone-CRH test in patients with remitted depression.

F. Holsboer, A. Zobel, R. Frieboes, 1999, The American journal of psychiatry.

The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders.

I. Heuser, F. Holsboer, Isabella Heuser, 1994, Journal of psychiatric research.

Acute and chronic neuroendocrine effects of interferon‐β 1a in multiple sclerosis

F. Holsboer, F. Then Bergh, C. Lechner, 2007, Clinical endocrinology.

Symposia Abstracts

Lisa Y. M. Chuah, P. K. Banerjee, J. Siegel, 2005 .

Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial.

F. Kiefer, K. Wiedemann, M. Kellner, 2004, Archives of general psychiatry.

Distraction versus focusing during VR exposure therapy for acrophobia: A randomized controlled trial.

P. Zwanzger, A. Mühlberger, A. Yassouridis, 2023, Journal of behavior therapy and experimental psychiatry.

Overnight suppression of HPA axis after mineraolocorticoid receptor stimulation: A sleep endocrine study

A. Agorastos, K. Wiedemann, M. Kellner, 2015, Psychiatry Research.

Ghrelin Levels Increase After Pictures Showing Food

Axel Steiger, Martin Dresler, Michael Kluge, 2012, Obesity.

Microstructure of the non‐rapid eye movement sleep electroencephalogram in patients with newly diagnosed Parkinson's disease: Effects of dopaminergic treatment

C. Trenkwalder, B. Hogl, E. Friess, 2002, Movement disorders : official journal of the Movement Disorder Society.

Adrenocorticotropic hormone in serial cerebrospinal fluid in man – Subject to acute regulation by the hypothalamic-pituitary-adrenocortical system?

K. Wiedemann, M. Kellner, A. Yassouridis, 2016, Psychiatry Research.

Endocrine rhythms in patients with restless legs syndrome

C. Trenkwalder, M. Uhr, T. Wetter, 2002, Journal of Neurology.

Sleep and Active Renin Levels – Interaction with Age, Gender, Growth Hormone and Cortisol

A. Steiger, F. Holsboer, M. Uhr, 2010, Neuropsychobiology.

Sleep and periodic leg movement patterns in drug-free patients with Parkinson's disease and multiple system atrophy.

T. Wetter, T. Pollmächer, C. Trenkwalder, 2000, Sleep.

Does Pregnenolone Enhance Exposure Therapy in Obsessive-Compulsive Disorder? – A Pilot, Interim Report of a Randomized, Placebo-Controlled, Double-Blind Study

K. Wiedemann, M. Kellner, A. Yassouridis, 2016, Pharmacopsychiatry.

Progesterone reduces wakefulness in sleep EEG and has no effect on cognition in healthy postmenopausal women

M. Dresler, A. Steiger, J. Zihl, 2008, Psychoneuroendocrinology.

Cortisol, DHEA and DHEA-S during exposure therapy in patients with obsessive-compulsive disorder – secretion patterns and prediction of treatment response

L. Jelinek, C. Muhtz, K. Wiedemann, 2020, Psychiatry Research.

Effects of Chronic Posttraumatic Stress Disorder on Metabolic Risk, Quality of Life, and Stress Hormones in Aging Former Refugee Children

C. Wittekind, C. Muhtz, K. Wiedemann, 2011, The Journal of nervous and mental disease.

[Long-term consequences of flight and expulsion in former refugee children].

L. Jelinek, C. Wittekind, C. Muhtz, 2011, Psychotherapie, Psychosomatik, medizinische Psychologie.

A combined dexamethasone/corticotropin-releasing hormone test in patients with chronic PTSD--first preliminary results.

C. Muhtz, K. Wiedemann, M. Kellner, 2008, Journal of psychiatric research.

Increased alpha activity in REM sleep in de novo patients with Parkinson's disease

T. Wetter, B. Högl, C. Trenkwalder, 2001, Movement disorders : official journal of the Movement Disorder Society.

A New Way of Identifying Biomarkers in Biomedical Basic-Research Studies

F. Leisch, A. Steiger, A. Yassouridis, 2012, PloS one.

Ghrelin increases slow wave sleep and stage 2 sleep and decreases stage 1 sleep and REM sleep in elderly men but does not affect sleep in elderly women

M. Dresler, A. Steiger, M. Gazea, 2010, Psychoneuroendocrinology.

Ghrelin administered in the early morning increases secretion of cortisol and growth hormone without affecting sleep

A. Steiger, M. Kluge, A. Yassouridis, 2007, Psychoneuroendocrinology.

Increased nocturnal secretion of ACTH and cortisol in obsessive compulsive disorder.

M. Dresler, A. Steiger, H. Künzel, 2007, Journal of psychiatric research.

Cerebrospinal Fluid Biomarkers for Major Depression Confirm Relevance of Associated Pathophysiology

Christine A. Miller, F. Holsboer, C. Turck, 2012, Neuropsychopharmacology.

[Deglutition disorders in neurological patients. A prospective study of diagnosis, pattern of impairment, therapy and outcome].

C. Hannig, E. Wagner-Sonntag, M. Prosiegel, 2002, Der Nervenarzt.

Sleep in pituitary insufficient patients compared to patients with depression and healthy controls at baseline and after challenge with CRH.

A. Steiger, J. Schopohl, H. Künzel, 2020, Journal of psychiatric research.

Overnight metyrapone and combined dexamethasone/metyrapone tests in post-traumatic stress disorder: preliminary findings

C. Otte, K. Wiedemann, M. Kellner, 2004, European Neuropsychopharmacology.

Annual Conference of the Swiss Society of Sleep Research, Sleep Medicine and Chronobiology (SSSSC) and the Swiss Society of Biological Psychiatry (SSBP). Sleepless Mind. Mindless Sleep? Bern, March 25 and 26, 2009

T. Hansen, K. D. Jakobsen, J. Amsterdam, 2009, Neuropsychobiology.

Sleep onset REM periods in obsessive compulsive disorder

M. Dresler, A. Steiger, M. Kluge, 2006, Psychiatry Research.

Acute cortisol administration increases sleep depth and growth hormone release in patients with major depression.

F. Holsboer, M. Uhr, E. Friess, 2008, Journal of psychiatric research.

Corticosteroid receptor function is decreased in depressed patients.

F. Holsboer, S. Modell, A. Yassouridis, 1997, Neuroendocrinology.

Effects of intranasal progesterone on sleep EEG and hormone secretion in menopauseal women

A. Steiger, C. Mattern, M. Uhr, 2013 .

Effects of intravenous corticotropin-releasing hormone upon sleep EEG in young healthy women

M. Dresler, A. Steiger, M. Kluge, 2008 .

Growth hormone-releasing hormone and corticotropin-releasing hormone enhance non-rapid-eye-movement sleep after sleep deprivation.

A. Steiger, F. Holsboer, M. Uhr, 2006, American journal of physiology. Endocrinology and metabolism.

Central Administration of IL-1 Reduces Anxiety and Induces Sickness Behaviour in Rats

F. Holsboer, R. Landgraf, A. Yassouridis, 1997, Pharmacology Biochemistry and Behavior.

Sociodemographic characteristics and length of psychiatric hospital stay: Application of a proportional hazards model

H. Pfister, A. Yassouridis, R. Laessle, 1988, Acta psychiatrica Scandinavica.

Differential effects to CCK-4-induced panic by dexamethasone and hydrocortisone

K. Wiedemann, M. Kellner, H. Jahn, 2012, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Time of interferon-β 1a injection and duration of treatment affect clinical side effects and acute changes of plasma hormone and cytokine levels in multiple sclerosis patients

T. Pollmächer, F. Weber, C. Trenkwalder, 2007 .

Modulation of the mineralocorticoid receptor as add-on treatment in depression: a randomized, double-blind, placebo-controlled proof-of-concept study.

C. Otte, S. Moritz, K. Hinkelmann, 2009, Journal of psychiatric research.

Does Pregnenolone Enhance Exposure Therapy in Obsessive-Compulsive Disorder? – A Pilot, Interim Report of a Randomized, Placebo-Controlled, Double-Blind Study

M. Kellner, A. Yassouridis, S. Nowack, 2016, Pharmacopsychiatry.

Ghrelin enhances the nocturnal secretion of cortisol and growth hormone in young females without influencing sleep

M. Dresler, A. Steiger, M. Uhr, 2007, Psychoneuroendocrinology.

Auricular Acupuncture Versus Progressive Muscle Relaxation in Patients with Anxiety Disorders or Major Depressive Disorder: A Prospective Parallel Group Clinical Trial

C. Muhtz, A. Agorastos, M. Kellner, 2017, Deutsche Zeitschrift für Akupunktur.

Ghrelin suppresses secretion of FSH in males

A. Steiger, M. Uhr, M. Kluge, 2009, Clinical endocrinology.